LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy
Clinical trial NCT02985125 · COMPLETED
Trial details
- NCT number
- NCT02985125
- Sponsor
- Georgetown University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-04
- Primary completion
- 2019-07-24
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.